SpiderwortSpiderwort
Spiderwort

Spiderwort

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

2015Active17

About

Spiderwort Biotechnologies Inc. is a biotechnology company focused on creating innovative, plant-based biomaterials derived from cellulose. These materials serve as scaffolds for regenerative medicine, tissue engineering, and medical aesthetics, with promising applications in treating spinal cord injuries and soft tissue regeneration. The company aims to advance clinical trials for its products, CelluBridge and CelluJuve.

Technology stack

detected 2026-06-17
Est. monthly stack spend~$120/mo
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Spiderwort do?

Spiderwort Biotechnologies Inc. is a biotechnology company focused on creating innovative, plant-based biomaterials derived from cellulose. These materials serve as scaffolds for regenerative medicine, tissue engineering, and medical aesthetics, with promising applications in treating spinal cord injuries and soft tissue regeneration. The company aims to advance clinical trials for its products, CelluBridge and CelluJuve.

How much funding has Spiderwort raised?

Spiderwort has raised a total of $16M in funding. The most recent round on record is Series A.

Where is Spiderwort headquartered?

Spiderwort is headquartered in Ottawa, Canada.

When was Spiderwort founded?

Spiderwort was founded in 2015.

What industry does Spiderwort operate in?

Spiderwort operates in Biotechnology, Regenerative Medicine, Tissue Engineering, Medical Devices, HealthTech, Biomaterials.

How many employees does Spiderwort have?

Spiderwort has approximately 17 people on record.